11.40
+0.30
+(2.70%)
As of 8:16:34 AM GMT+1. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 22.98M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| VARGEESE CHANDRA Officer | Conversion of Exercise of derivative security at price 2.48 per share. | Direct | 114,080 | Jan 23, 2025 |
| BOLNO PAUL B. M.D. Chief Executive Officer | Conversion of Exercise of derivative security at price 2.48 per share. | Direct | 124,000 | Nov 25, 2024 |
| BOLNO PAUL B. M.D. Chief Executive Officer | Sale at price 15.00 per share. | Direct | 750,000 | Nov 25, 2024 |
| BOLNO PAUL B. M.D. Chief Executive Officer | Sale at price 14.32 per share. | Direct | 733,671 | Nov 15, 2024 |
| FRANCIS CHRISTOPHER JOHN Officer | Conversion of Exercise of derivative security at price 8.17 per share. | Direct | 294,120 | Nov 8, 2024 |
| FRANCIS CHRISTOPHER JOHN Officer | Sale at price 16.00 per share. | Direct | 576,000 | Nov 8, 2024 |
| FRANCIS CHRISTOPHER JOHN Officer | Conversion of Exercise of derivative security at price 2.48 - 3.14 per share. | Direct | 371,410 | Oct 16, 2024 |
| BOLNO PAUL B. M.D. Chief Executive Officer | Sale at price 15.00 per share. | Direct | 1,357,110 | Oct 16, 2024 |
| FRANCIS CHRISTOPHER JOHN Officer | Sale at price 13.00 - 14.00 per share. | Direct | 2,855,051 | Oct 16, 2024 |
| MORAN KYLE Chief Financial Officer | Conversion of Exercise of derivative security at price 2.48 per share. | Direct | 62,000 | Oct 11, 2024 |
| GSK PLC Beneficial Owner of more than 10% of a Class of Security | Purchase at price 8.00 per share. | Indirect | 22,335,440 | Sep 27, 2024 |
| MORAN KYLE Chief Financial Officer | Sale at price 9.00 per share. | Direct | 154,314 | Sep 25, 2024 |
| BOLNO PAUL B. M.D. Chief Executive Officer | Sale at price 5.78 per share. | Direct | 279,555 | Aug 21, 2024 |
| CORRIGAN MARK Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 12, 2024 |
| HENRY CHRISTIAN O Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 12, 2024 |
| RAWCLIFFE ADRIAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 12, 2024 |
| VERDINE GREGORY L Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 12, 2024 |
| WAGNER HEIDI L Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 12, 2024 |
| TAKANASHI KEN Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 12, 2024 |
| RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | Indirect | 0 | Aug 12, 2024 |
| TAN AIK NA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 12, 2024 |
| VARGEESE CHANDRA Chief Technology Officer | Conversion of Exercise of derivative security at price 2.48 per share. | Direct | 169,161 | Jul 22, 2024 |
| MORAN KYLE Chief Financial Officer | Sale at price 6.17 per share. | Direct | 96,421 | Apr 3, 2024 |
| RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 4.16 per share. | Indirect | 4,160,000 | Dec 11, 2023 |
| RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 4.16 per share. | Indirect | 4,160,000 | Dec 11, 2023 |
| GSK PLC Beneficial Owner of more than 10% of a Class of Security | Purchase at price 5.00 per share. | Indirect | 16,500,000 | Dec 7, 2023 |
| MORAN KYLE Chief Financial Officer | Sale at price 4.75 per share. | Direct | 176,119 | Aug 23, 2023 |
| MORAN KYLE Chief Financial Officer | Sale at price 4.04 per share. | Direct | 39,305 | Feb 16, 2023 |
| BOLNO PAUL B. M.D. Chief Executive Officer | Sale at price 4.04 per share. | Direct | 118,776 | Feb 16, 2023 |
| VARGEESE CHANDRA Chief Technology Officer | Sale at price 4.03 per share. | Direct | 41,303 | Feb 16, 2023 |
| FRANCIS CHRISTOPHER JOHN Officer | Sale at price 4.03 per share. | Direct | 41,340 | Feb 16, 2023 |
Related Tickers
9IP1.F Rocket Pharmaceuticals, Inc.
9.94
+3.37%
0K4.BE Akero Therapeutics Inc
52.60
-2.12%
BBZA.F BB Biotech AG Ord
43.60
+2.35%
0K4.F Akero Therapeutics, Inc.
53.02
+2.71%
COYA Coya Therapeutics, Inc.
6.17
+5.29%
22UA.DE BioNTech SE
118.40
-0.17%
MTEM Molecular Templates, Inc.
0.0001
-66.67%
EDSA Edesa Biotech, Inc.
1.9483
+3.08%
ANIX Anixa Biosciences, Inc.
2.8716
-2.33%
MGNX MacroGenics, Inc.
3.1400
+4.32%